AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Morgan Advanced Materials PLC

Director's Dealing Sep 17, 2021

4597_dirs_2021-09-17_a33a089e-c947-41e2-a947-08808bd9ffeb.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2005M

Morgan Advanced Materials PLC

17 September 2021

17 September 2021

Morgan Advanced Materials plc

Notification of transactions of Directors/Persons Discharging Managerial Responsibilities

1

Details of the person discharging managerial responsibilities / persons closely associated

a)

Name

Clement Woon

2

Reason for the notification

a)

Position/status

PDMR - Non Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Morgan Advanced Materials Plc

b)

LEI

I4K14LL95N2PHDL7EG85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each

GB0006027295

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
GBP 3.89 9,719

d)

Aggregated information

-     Aggregated volume

-     Price

N/A

e)

Date of the transaction

2021-09-17

f) 

Place of the transaction

London Stock Exchange (XLON)

This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.

Stephanie Mackie         

Morgan Advanced Materials plc

01753 837000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFESAEIDLIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.